Intralesional Injection of Triamcinolone Acetonide for Subcutaneous Lipoma causing Musculoskeletal and Neurologic Symptoms

Benign subcutaneous lipomas can cause musculoskeletal pain and nerve impingement. We hypothesized that the potent lipolytic and atrophic effect of 40mg/mL triamcinolone acetonide would atrophy symptomatic lipomas so surgical excision could be avoided. This was a cohort study. This study took place i...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical and aesthetic dermatology 2018-05, Vol.11 (5), p.38
Main Authors: Hayward, William A, Sibbitt, Wilmer L, Sibbitt, Randy R, Muruganandam, Maheswari, Rolle, Noelle A, Fangtham, Monthida, Suzanne Emil, N, Kettwich, Scarlett K
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Benign subcutaneous lipomas can cause musculoskeletal pain and nerve impingement. We hypothesized that the potent lipolytic and atrophic effect of 40mg/mL triamcinolone acetonide would atrophy symptomatic lipomas so surgical excision could be avoided. This was a cohort study. This study took place in an ultrasound injection clinic. Eight subjects with painful symptomatic lipoma were included. Preprocedurally, the margins of the lipomas were palpated and marked with ink, then measured in centimeters (cm). Small lipomas (1-3cm) were injected with 40mg triamcinolone acetonide, while large lipomas (4-6cm) were injected with 80mg of triamcinolone acetonide. The subjects were reassessed at a four-month follow-up appointment and then again at one year and two years after the procedure. Pre-injection, all eight subjects had symptoms related to impingement or pain with compression of the lipoma. At four months post-injection, none of the patients had symptoms attributable to the lipoma (
ISSN:1941-2789
2689-9175